Characterization and immunotherapeutic potential of gammadelta T-cells in patients with glioblastoma.
about
Empowering gamma delta T cells with antitumor immunity by dendritic cell-based immunotherapyWhat lessons can be learned from γδ T cell-based cancer immunotherapy trials?Harnessing the power of Vδ2 cells in cancer immunotherapyAdoptive cell therapies for glioblastomaEngineered drug resistant γδ T cells kill glioblastoma cell lines during a chemotherapy challenge: a strategy for combining chemo- and immunotherapyEnhanced anti-tumor effect of zoledronic acid combined with temozolomide against human malignant glioma cell expressing O6-methylguanine DNA methyltransferaseImmunotherapy of brain cancers: the past, the present, and future directions.CMV-independent lysis of glioblastoma by ex vivo expanded/activated Vδ1+ γδ T cells.Dynamics of Circulating γδ T Cell Activity in an Immunocompetent Mouse Model of High-Grade Glioma.Poor survival in glioblastoma patients is associated with early signs of immunosenescence in the CD4 T-cell compartment after surgery.Cellular immunotherapy for high-grade glioma.Quantitative peripheral blood perturbations of γδ T cells in human disease and their clinical implications.Cytotoxic and regulatory properties of circulating Vδ1+ γδ T cells: a new player on the cell therapy field?A new hope in immunotherapy for malignant gliomas: adoptive T cell transfer therapy.Gamma Delta T-lymphocytes in Hepatitis C and Chronic Liver Disease.The safety of allogeneic innate lymphocyte therapy for glioma patients with prior cranial irradiation.Cytotoxic human peripheral blood-derived γδT cells kill glioblastoma cell lines: implications for cell-based immunotherapy for patients with glioblastoma.Zoledronic acid enhances Vδ2 T-lymphocyte antitumor response to human glioma cell lines.NKG2D- and T-cell receptor-dependent lysis of malignant glioma cell lines by human γδ T cells: Modulation by temozolomide and A disintegrin and metalloproteases 10 and 17 inhibitorsAssociation between peripheral γδ T cell subsets and disease progression of severe fever with thrombocytopenia syndrome virus infection.Phase I study of bromohydrin pyrophosphate (BrHPP, IPH 1101), a Vgamma9Vdelta2 T lymphocyte agonist in patients with solid tumors.Antitumor effects of minodronate, a third-generation nitrogen-containing bisphosphonate, in synergy with γδT cells in human glioblastoma in vitro and in vivo.Apoptosis Induced via Gamma Delta T Cell Antigen Receptor "Blocking" Antibodies: A Cautionary TaleIn-depth immunophenotyping of patients with glioblastoma multiforme: Impact of steroid treatment.
P2860
Q26781175-3499C2CF-86D8-4638-8020-6C6E5B2DD836Q26849323-52080EBD-0C95-479D-8070-C5CED349BC21Q27027547-D57814C2-84D4-46B1-9A96-F1314512F041Q27030863-E77F8804-D697-44BE-A1C5-29E2C3969F1CQ28485036-C7ED8403-B345-42E0-ACD0-F5D381F8AC37Q28541765-A17CB8EE-B232-47F6-85B5-5E7BB038E456Q34701587-178DEE64-E0CA-4EF0-B56A-223C0E338380Q34946005-AD637699-CB28-404E-823C-F51FCA695E88Q35587132-65E13D0D-2AC1-4F8F-9472-A57EBB17F35AQ36060293-DF64F410-ACFC-426E-BB39-DA2BE2EA9FD1Q37851972-04B8CC30-E95C-45EA-9D60-8CDE62D9AB14Q38152686-3348C5DA-9A78-4336-88A6-0C3A149A3368Q38217512-63F9271E-F3CB-4D73-96B8-392C751E3569Q38227889-D53AFC34-7DBB-4A53-9B27-BB09B063488EQ38247990-C39AB1C6-13C5-4FBF-81BB-9F0C7846CC73Q38910282-73890BD1-A614-4271-8770-AAE9DCC122DFQ39092574-7E3DDC5E-5A5F-4EC8-85B7-4B3AD2225D76Q39558094-A54491F0-A55E-45CF-BA98-D8C9888D4C34Q39798606-5BAABA08-1B60-4B67-8F67-30AF83499CA4Q40041163-34D09E7E-6DF2-43A3-AE1D-EFBBBC5453FFQ40356007-BFF88403-5C48-49E1-8427-8C1B48DBFC67Q40620344-A0870904-B70F-46FB-BA30-B3647675F4BDQ40989863-D974A4A2-450C-40EB-B2EE-933831FB8D59Q52780147-DC1ADC67-570A-4820-8773-E6A52966831F
P2860
Characterization and immunotherapeutic potential of gammadelta T-cells in patients with glioblastoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Characterization and immunothe ...... in patients with glioblastoma.
@en
Characterization and immunothe ...... in patients with glioblastoma.
@nl
type
label
Characterization and immunothe ...... in patients with glioblastoma.
@en
Characterization and immunothe ...... in patients with glioblastoma.
@nl
prefLabel
Characterization and immunothe ...... in patients with glioblastoma.
@en
Characterization and immunothe ...... in patients with glioblastoma.
@nl
P2093
P2860
P1433
P1476
Characterization and immunothe ...... in patients with glioblastoma.
@en
P2093
Catalina Suarez-Cuervo
G Yancey Gillespie
James M Markert
L Burt Nabors
Lawrence S Lamb
Nichole L Bryant
Richard D Lopez
Sreelatha Meleth
P2860
P304
P356
10.1215/15228517-2008-111
P577
2009-02-11T00:00:00Z